Journal of International Oncology ›› 2017, Vol. 44 ›› Issue (1): 38-40.doi: 10.3760/cma.j.issn.1673-422X.2017.01.010

Previous Articles     Next Articles

Nucleic acid aptamer and its research progress in glioma

Kou Zhewen, Peng Li, Zhang Xingmei   

  1. Department of Neurobiology, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China
  • Online:2017-01-08 Published:2016-12-07
  • Contact: Zhang Xingmei, Email: zxmray@hotmail.com E-mail:zxmray@hotmail.com
  • Supported by:

    National Natural Science Foundation of China (81272509, 30973481)

Abstract: Nucleic acid aptamer is an oligonucleotide generated by the systematic evolution of ligands by exponential enrichment (SELEX) process from oligonucleotide library. Nucleic acid aptamer can bind to various targets with high specificity and  can recognize or inhibit the biological activity of targeting molecular. Gliomaspecific aptamers are developed by either targeting the glioma cells or known biomarkers, which can be coupled with nanoparticles, drugs or molecular probes, and can be applied in the imaging, targeted therapy and drug delivery of glioma.

Key words: Glioma, Aptamers, nucleotide